In addition to its injectable formulation, Jade Pharmaceutical (JPI) anticipates offering Goodnak in capsules and an easy-to-apply lotion.
Based on general market information, the proposed pricing for these new formulations will be approximately $40 per unit, with 60% gross profit margins. JPI plans to sell both products through existing distribution channels within the Henan, Sichuan, Guizhou, Shanxi, Xinjiang, Gansu, Hunnan, Zhejiang, Fujian, Liaoning and Heilongjiang Provinces of China.
In addition to China, AMDL believes both products will be good candidates for export to the North American and European markets.